fr
Article scientifique
Anglais

Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy

Publié dansJournal of clinical epidemiology, vol. 62, no. 6, p. 632-641
Date de publication2009
Résumé

OBJECTIVE: Hierarchical modeling has been proposed as a solution to the multiple exposure problem. We estimate associations between metabolic syndrome and different components of antiretroviral therapy using both conventional and hierarchical models. STUDY DESIGN AND SETTING: We use discrete time survival analysis to estimate the association between metabolic syndrome and cumulative exposure to 16 antiretrovirals from four drug classes. We fit a hierarchical model where the drug class provides a prior model of the association between metabolic syndrome and exposure to each antiretroviral. RESULTS: One thousand two hundred and eighteen patients were followed for a median of 27 months, with 242 cases of metabolic syndrome (20%) at a rate of 7.5 cases per 100 patient years. Metabolic syndrome was more likely to develop in patients exposed to stavudine, but was less likely to develop in those exposed to atazanavir. The estimate for exposure to atazanavir increased from hazard ratio of 0.06 per 6 months' use in the conventional model to 0.37 in the hierarchical model (or from 0.57 to 0.81 when using spline-based covariate adjustment). CONCLUSION: These results are consistent with trials that show the disadvantage of stavudine and advantage of atazanavir relative to other drugs in their respective classes. The hierarchical model gave more plausible results than the equivalent conventional model.

Mots-clés
  • Adult
  • Anti-HIV Agents/adverse effects
  • Anti-Retroviral Agents/ adverse effects
  • Antiretroviral Therapy, Highly Active/adverse effects
  • Female
  • HIV Infections/complications/ drug therapy
  • HIV Protease Inhibitors/adverse effects
  • Humans
  • Male
  • Metabolic Syndrome X/ chemically induced
  • Models, Statistical
  • Oligopeptides/adverse effects
  • Prospective Studies
  • Pyridines/adverse effects
  • Reverse Transcriptase Inhibitors/adverse effects
  • Risk Factors
  • Stavudine/adverse effects
  • Switzerland
Citation (format ISO)
YOUNG, Jim et al. Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy. In: Journal of clinical epidemiology, 2009, vol. 62, n° 6, p. 632–641. doi: 10.1016/j.jclinepi.2008.07.015
Fichiers principaux (1)
Article
accessLevelRestricted
Identifiants
ISSN du journal0895-4356
438vues
0téléchargements

Informations techniques

Création21.06.2010 10:27:15
Première validation21.06.2010 10:27:15
Heure de mise à jour14.03.2023 15:46:20
Changement de statut14.03.2023 15:46:20
Dernière indexation12.02.2024 18:40:22
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack